Abstract
Medulloblastoma (MB) is the most common pediatric tumor of the central nervous system. It is an embryonic neuroepithelial tumor arising from the cerebellum and occurs in 20% of children diagnosed with malignant tumor in the CNS. Clinical prognosis follows three criteria: age of the patient, the extent of surgical resection and the spread of disease. Treatment of medulloblastoma consists o…